Feel Therapeutics

San Francisco, CA · Founded 2015 · Privately Held (backing)

Developer of a digital precision medicine company designed to bring objective data and passive monitoring for mental health. Feel Therapeutics is based in San Francisco, CA and was founded in 2015. Its last reported valuation was $22 million in Oct 2019. It has raised $33.6 million across 1 recorded round; the latest was a $7.9 million early-stage round in Aug 2020.

Last reported valuation
$22.0M
Oct 2026
Priced at
—
Total raised
$33.6M
Last round
Early Stage VC
Aug 2020
What is Feel Therapeutics worth?
$22.0Mlast reported valuation · Oct 2026

Feel Therapeutics's last reported valuation, Oct 2019. Nothing priced has surfaced since.

Free account
More of Feel Therapeutics with a free account
  • ·The complete investor list: 23 names
  • ·Watch Feel Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Feel Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Aug 2020Early Stage VC$7.9M▮
Unlock post-money valuations

Membership and data by Private Market View

Feel Therapeutics valuation

Feel Therapeutics's last reported valuation was $22 million in Oct 2019. No priced round, secondary trade or fund mark has surfaced since.

How much has Feel Therapeutics raised?

Feel Therapeutics has raised $33.6 million in total; 1 of its rounds is on record. The largest on record was a $7.9 million early-stage round in Aug 2020.

Feel Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Apr 2025 ($7.9 million sold to 34 investors).

How Feel Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Feel Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Feel Therapeutics

What is Feel Therapeutics worth?
Feel Therapeutics is valued at $22.0M as of Oct 2026. Feel Therapeutics's last reported valuation, Oct 2019. Nothing priced has surfaced since.
How much has Feel Therapeutics raised?
Feel Therapeutics has raised $33.6M in total funding across 1 recorded rounds.
When did Feel Therapeutics last raise?
Feel Therapeutics last raised in Aug 2020 (Early Stage VC), raising $7.9M.